| Product Code: ETC9969620 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Lymphedema Diagnostics Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Lymphedema Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Lymphedema Diagnostics Market - Industry Life Cycle |
3.4 United States (US) Lymphedema Diagnostics Market - Porter's Five Forces |
3.5 United States (US) Lymphedema Diagnostics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Lymphedema Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 United States (US) Lymphedema Diagnostics Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.8 United States (US) Lymphedema Diagnostics Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.9 United States (US) Lymphedema Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United States (US) Lymphedema Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing prevalence of lymphedema in the US population |
4.2.2 Increasing awareness about early diagnosis and treatment of lymphedema |
4.2.3 Technological advancements in diagnostic tools for lymphedema detection |
4.3 Market Restraints |
4.3.1 Limited reimbursement policies for lymphedema diagnostics |
4.3.2 High cost associated with diagnostic procedures |
4.3.3 Lack of trained healthcare professionals for accurate diagnosis of lymphedema |
5 United States (US) Lymphedema Diagnostics Market Trends |
6 United States (US) Lymphedema Diagnostics Market, By Types |
6.1 United States (US) Lymphedema Diagnostics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Lymphedema Diagnostics Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Lymphedema Diagnostics Market Revenues & Volume, By Primary, 2021- 2031F |
6.1.4 United States (US) Lymphedema Diagnostics Market Revenues & Volume, By Secondary, 2021- 2031F |
6.2 United States (US) Lymphedema Diagnostics Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Lymphedema Diagnostics Market Revenues & Volume, By Lymphoscintigraphy, 2021- 2031F |
6.2.3 United States (US) Lymphedema Diagnostics Market Revenues & Volume, By Magnetic Resonance Imaging, 2021- 2031F |
6.2.4 United States (US) Lymphedema Diagnostics Market Revenues & Volume, By Ultrasound Imaging, 2021- 2031F |
6.2.5 United States (US) Lymphedema Diagnostics Market Revenues & Volume, By Computed Tomography, 2021- 2031F |
6.2.6 United States (US) Lymphedema Diagnostics Market Revenues & Volume, By X-Ray Lymphography, 2021- 2031F |
6.2.7 United States (US) Lymphedema Diagnostics Market Revenues & Volume, By Bio-impedance Analysis, 2021- 2031F |
6.3 United States (US) Lymphedema Diagnostics Market, By Disease Type |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Lymphedema Diagnostics Market Revenues & Volume, By Cancer, 2021- 2031F |
6.3.3 United States (US) Lymphedema Diagnostics Market Revenues & Volume, By Inflammatory Diseases, 2021- 2031F |
6.3.4 United States (US) Lymphedema Diagnostics Market Revenues & Volume, By Cardiovascular Disease, 2021- 2031F |
6.4 United States (US) Lymphedema Diagnostics Market, By Treatment Type |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Lymphedema Diagnostics Market Revenues & Volume, By Surgery, 2021- 2031F |
6.4.3 United States (US) Lymphedema Diagnostics Market Revenues & Volume, By Compression Therapy, 2021- 2031F |
6.5 United States (US) Lymphedema Diagnostics Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Lymphedema Diagnostics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 United States (US) Lymphedema Diagnostics Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.5.4 United States (US) Lymphedema Diagnostics Market Revenues & Volume, By Research and Academic Institutes, 2021- 2031F |
7 United States (US) Lymphedema Diagnostics Market Import-Export Trade Statistics |
7.1 United States (US) Lymphedema Diagnostics Market Export to Major Countries |
7.2 United States (US) Lymphedema Diagnostics Market Imports from Major Countries |
8 United States (US) Lymphedema Diagnostics Market Key Performance Indicators |
8.1 Number of new lymphedema cases diagnosed annually |
8.2 Adoption rate of advanced diagnostic technologies in lymphedema diagnosis |
8.3 Patient satisfaction with the diagnostic process and accuracy of results |
9 United States (US) Lymphedema Diagnostics Market - Opportunity Assessment |
9.1 United States (US) Lymphedema Diagnostics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Lymphedema Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 United States (US) Lymphedema Diagnostics Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.4 United States (US) Lymphedema Diagnostics Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.5 United States (US) Lymphedema Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United States (US) Lymphedema Diagnostics Market - Competitive Landscape |
10.1 United States (US) Lymphedema Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Lymphedema Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here